Klement Podnar, Bojan Molj, and Urs̆a Golob, (2007). How Reference Pricing for Pharmaceuticals Can Increase Generic Share of Market: The Slovenian Experience. Journal of Public Policy & Marketing: Vol. 26, No. 1, pp. 89-101.
doi: 10.1509/jppm.26.1.89

How Reference Pricing for Pharmaceuticals Can Increase Generic Share of Market: The Slovenian Experience

Klement Podnar 1,

1Assistant professor, Faculty of Social Sciences, Marketing Communication and Public Relations Department, University of Ljubljana.


Bojan Molj 2,

2Brand manager, Hofer d.o.o.


Urs̆a Golob 3

3Teaching assistant, Faculty of Social Sciences, Marketing Communication and Public Relations Department, University of Ljubljana.




Abstract

The authors review how part of the Slovenian pharmaceutical market was influenced by reference pricing. On the basis of their descriptive analysis, they argue that the reference-pricing system caused a dramatic decrease of the market shares of originators on the one hand and an increase in the share of generic drugs on the other hand.

Cited by

Pamina Koenig, Megan MacGarvie. (2011) Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe. Journal of Health Economics
Online publication date: 1-Jul-2011.
CrossRef
Jaume Puig-Junoy. (2010) Impact of European Pharmaceutical Price Regulation on Generic Price Competition. PharmacoEconomics 28:8, 649-663
Online publication date: 1-Aug-2010.
CrossRef